Apr 18 2025
A randomized, double-blind clinical trial conducted at Buriram Hospital in Thailand found that daily sublingual cannabidiol (CBD) was safe for individuals with Parkinson’s disease and led to improvements in naming ability, an important aspect of cognitive function. The trial included 60 Parkinson’s disease patients, evenly split between those receiving a CBD-enriched product and those given …
Apr 18 2025
A new study finds that hemp crude oil may offer an effective alternative to antibiotics for combating a harmful bacterium commonly found in grain-finished beef cattle. Researchers from the USDA Agricultural Research Service, the University of Kentucky, and Kansas State University have published findings in the journal Anaerobe showing that Cannabis sativa L. (hemp) crude …
Apr 18 2025
A new study published in the Journal of Forensic Science suggests artificial intelligence may soon streamline forensic cannabis identification, replacing slower traditional methods. For the study, researchers from the Israel Institute of Technology developed a deep learning system capable of detecting cannabis by analyzing microscopic images of plant trichomes—specifically, non-glandular trichome hairs, a distinguishing feature …
Apr 18 2025
A new study published by the journal Brain and Behavior, and published online by the National Library of Medicine, found that cannabis-based medicinal products (CBMPs) may improve quality of life for individuals with treatment-resistant epilepsy. The study, conducted by researchers at Imperial College London and Kings College London, analyzed data from 134 patients enrolled in …
Apr 17 2025
According to the results of a new study, cannabidiol (CBD) significantly strengthens the epithelial barrier in Peyer’s Patches and may support the prevention of inflammation-related conditions. Conducted by researchers at Freie Universität Berlin and the University of Jordan, the study examined the effects of CBD on intestinal tissues using an ex vivo porcine model. Researchers …
Apr 17 2025
A new study published in the International Journal of Molecular Sciences suggests that the cannabinoid cannabinerol (CBNR) may play a role in reversing RNA splicing abnormalities linked to Alzheimer’s disease (AD). The study focused on how CBNR affects RNA splicing in an in vitro model using SH-SY5Y cells exposed to beta-amyloid (Aβ), a protein commonly …
Apr 17 2025
A new study published in the journal ACS Pharmacology & Translational Science finds that cannabinoids may offer a promising multitargeted approach for treating glaucomatous neurodegeneration, especially in patients who experience retinal damage without elevated intraocular pressure (IOP). Researchers from Jagran Lakecity University and Truba Institute of Pharmacy in India reviewed current evidence indicating that glaucoma, …
Apr 16 2025
On Tuesday, April 15, Frontiers in Oncology published the largest meta-analysis ever conducted on medical cannabis and its effects on cancer-related symptoms—a groundbreaking scientific achievement. Led by Cancer Playbook, powered by Whole Health Oncology Institute (WHOI), this systematic research review aggregated data from over 10,000 peer-reviewed studies—a scale never before achieved in this field, and …
Apr 15 2025
The U.S. cannabis industry is on track to reach a market value of $76.39 billion by 2030, according to a new report from Research and Markets. This would represent an 11.5% compound annual growth rate (CAGR) from 2025 through the end of the decade, fueled by expanding legalization, increased consumer demand, and innovations in cultivation …
Apr 15 2025
Researchers from Thailand’s Kasetsart University have found that cannabis leaves can significantly improve the taste and quality of kombucha by boosting beneficial bacteria and reducing harsh acidity. The study, published by the journal Foods, examined the use of Thai cannabis leaves in kombucha brewed with assam green tea. The cannabis leaves were found to be …
